Researchers studied 187 isolates of C. difficile collected from patients ... A 31-year-old woman pregnant with twins developed severe colitis that evolved into toxic megacolon; both the patient ...

Joyce Beatty (D-OH) on cancer research and treatment Javascript must be enabled in order to access C-SPAN videos. *This text was compiled from uncorrected Closed Captioning.

There are about 500,000 cases of C. difficile each year; about one in six people with the infection will see it come back within two to eight weeks of the initial infection. “Treatment of C.

Ulcerative colitis medications help control the symptoms of ulcerative colitis (UC) and prevent flare-ups or relapses. UC is a chronic inflammatory bowel disease. It's an autoimmune condition, meaning ...

BWL may lower costs and provide more timely care for urinary stones Break Wave lithotripsy was effective, with evidence of fragmentation in 88% of patients. After treatment, most patients had ...

Among the overarching trends is earlier and earlier treatment intensification to forestall development of metastases and castration-resistant prostate cancer (CRPC). Triplet therapy with docetaxel ...

Navigating type 2 diabetes treatment options can be complex, but finding the right approach is key. This guide will explore the various treatments available so you can make informed decisions and ...

By Lexy Perez Associate Editor Kate Middleton has shared that she has completed her chemotherapy treatment. In a video shared on Monday, the Princess of Wales shared that she is entering a “new ...

Kate Middleton is finished with her chemotherapy treatment. On Monday, the Princess of Wales shared a video of herself with Prince William and their children Prince George, Princess Charlotte ...

In the U.S. there are almost half a million infections each year and approximately 30,000 deaths. Dr. Thomas Louie of University of Calgary, Canada, principal investigator for this study, stated: ...

Elena Makovac does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...